1型糖尿病饮食模式对体重与血糖管理的临床试验荟萃分析
随机试验的极低至中等确定性证据未显示任何特定饮食模式具有优势;仅来自单臂低碳水化合物试验的极低质量证据提示HbA1c随时间改善(-0.63% [95% CI, -0.99 to -0.27])。需要随机试验确认特定饮食的疗效及精准营养是否优化血糖和体重管理。
要点
- 随机试验证据未显示任何特定饮食模式对1型糖尿病血糖或体重有优势。
- 单臂低碳水化合物试验的极低质量证据提示HbA1c可能改善(-0.63%)。
- 汇总置信区间宽提示个体间异质性,但罕有按参与者特征分层分析。
核心结论
- 随机试验的极低至中等确定性证据未显示任何特定饮食模式在1型糖尿病血糖或体重管理上具有优势。
- 来自单臂低碳水化合物试验的极低质量证据提示HbA1c随时间改善(-0.63% [95% CI, -0.99 to -0.27];-6.0 mmol/mol [-10.8 to -3.0])。
- 需要随机试验确认特定饮食的疗效及精准营养治疗是否优化1型糖尿病患者的血糖和体重。
研究设计与样本
- 研究为临床试验的荟萃分析,方案前瞻性注册(CRD42024519941)。
- 检索AMED、CINAHL、Cochrane Library、Ovid MEDLINE、Ovid Embase、Google Scholar和Web of Science Core Collection,时间从2011年1月至2024年6月。
- 纳入标准为临床 trials ≥4周、≥10名青年和/或成人、诊断1型糖尿病≥6个月且报告HbA1c或体重。
- 数据不足的研究及亚组差异按Synthesis without meta-analysis指南进行叙述性综合。
主要发现
- 随机试验的极低至中等确定性证据未显示任何特定饮食模式具有优势。
- 单臂低碳水化合物试验的极低质量证据提示HbA1c随时间改善(-0.63% [95% CI, -0.99 to -0.27];-6.0 mmol/mol [-10.8 to -3.0])。
- 汇总置信区间宽提示个体间异质性,但罕有按参与者特征分层分析。
临床怎么用
- 现有证据不支持为1型糖尿病患者常规推荐某一特定饮食模式以优于其他模式管理血糖或体重。
- 单臂低碳水化合物试验的极低质量证据提示HbA1c可能改善,但需随机试验确认,不能作为常规推荐依据。
- 应关注个体间异质性,但精准营养方法尚缺乏证据支持。
局限性
- 证据有限,无法进行亚组分析以指导精准营养方法。
- 单臂低碳水化合物试验的证据质量极低。
- 随机试验的汇总证据确定性为极低至中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medical nutrition therapy is fundamental for managing glycemia and weight in type 1 diabetes, yet dietary guidance specific to this population and relevant subgroups is lacking. PURPOSE: We synthesized the interventional literature investigating diet patterns for glycemic and weight management in youth and adults with type 1 diabetes, with attention to interindividual variation that suggests the need for precision approaches. The protocol was prospectively registered (CRD42024519941). DATA SOURCES: AMED, CINAHL, Cochrane Library, Ovid MEDLINE, Ovid Embase, Google Scholar, and Web of Science Core Collection were searched from January 2011 to June 2024. STUDY SELECTION: Clinical trials ≥4 weeks with ≥10 youth and/or adults diagnosed with type 1 diabetes ≥6 months prior and reporting glycated hemoglobin (HbA1c) or weight were included. DATA SYNTHESIS: Twelve studies with 668 participants were included. Data were pooled by random-effects models for HbA1c and weight. Studies with insufficient data and subgroup differences were narratively synthesized per Synthesis without meta-analysis guidelines. Pooled results of very low to moderate certainty evidence showed no advantage of any particular diet pattern in randomized trials. Very low-quality evidence from single-arm low carbohydrate trials suggested improved HbA1c over time (-0.63% [95% CI, -0.99 to -0.27]; -6.0 mmol/mol [-10.8 to -3.0]). Wide pooled CIs suggested between-person heterogeneity; however, stratification of results by participant characteristics was rarely performed. LIMITATIONS: Limited evidence precluded subgroup analyses to inform precision nutrition approaches. CONCLUSION: Randomized trials are needed to confirm the efficacy of specific diets and determine whether precision nutrition therapies optimize glycemia and weight in persons with type 1 diabetes.
引用
- Igudesman D, Nally LM, Grimshaw AA, et al. Dietary Patterns for Weight and Glycemic Management in Persons With Type 1 Diabetes: A Meta-analysis of Clinical Trials. J Clin Endocrinol Metab. 2025. PMID: 40795275. doi:10.1210/clinem/dgaf448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。